The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...

FRANKFURT: European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by ...

EUROPEAN shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

In addition to obesity, modifiable risk factors include a low-quality diet (such as high consumption of processed meats, ...

In a 10-1 vote, the U.S. FDA’s Psychopharmacologic Drugs Advisory Committee said Otsuka Pharmaceutical Co. Ltd.’s studies of its combination post-traumatic stress disorder (PTSD) treatment did not ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Kraft Heinz, whose Maxwell House and Gevalia would be hit hard by new duties on coffee beans, retained WilmerHale to lobby on tariffs beginning on May 1, according to a disclosure filing.

If you have a pension or investment portfolio there is one fund type that you must hold - and while it will have made you excellent returns, experts now warn its future is far more precarious.